ConductScience.org, home

Paper42076830

Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut-Kidney Axis Restoration and TLR4/NF-κB/NLRP3 Suppression.

Wang Y and 9 others. J Diabetes Res, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut-Kidney Axis Restoration and TLR4/NF-κB/NLRP3 Suppression. Papers, record 42076830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42076830

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut-Kidney Axis Restoration and TLR4/NF-κB/NLRP3 Suppression.
PubMed
Journal
J Diabetes Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Diabetic NephropathiesMajor topic
Toll-Like Receptor 4Major topic
NF-kappa BMajor topic
NLR Family, Pyrin Domain-Containing 3 ProteinMajor topic
Gastrointestinal MicrobiomeMajor topic
KidneyMajor topic
Drugs, Chinese HerbalMajor topic
Animals
Mice
Diabetes Mellitus, Experimental
Chromatography, Liquid
Tandem Mass Spectrometry
Mice, Inbred C57BL
Proteinuria
Intestinal Barrier Function
Cytokines
RNA, Ribosomal, 16S
Bacteria
Male
Colon
Lipopolysaccharides

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82374386National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138565643Short-chain fatty acids: linking diet, the microbiome and immunity.Nat Rev Immunol2024https://conductscience.org/library/papers/38565643PubMed
242076830Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut-Kidney Axis Restoration and TLR4/NF-κB/NLRP3 Suppression.J Diabetes Res2026https://conductscience.org/library/papers/42076830PubMed
332973502Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice.Front Pharmacol2020https://conductscience.org/library/papers/32973502PubMed
436794950A Novel Synbiotic Alleviates Autoimmune Hepatitis by Modulating the Gut Microbiota-Liver Axis and Inhibiting the Hepatic TLR4/NF-κB/NLRP3 Signaling Pathway.mSystems2023https://conductscience.org/library/papers/36794950PubMed
534604258Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease.Front Med (Lausanne)2021https://conductscience.org/library/papers/34604258PubMed
630273931Inflammation in Diabetic Kidney Disease.Nephron2019https://conductscience.org/library/papers/30273931PubMed
735661785Molecular mechanisms and therapeutic targets for diabetic kidney disease.Kidney Int2022https://conductscience.org/library/papers/35661785PubMed
837804821Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the "gut-kidney axis".Phytomedicine2023https://conductscience.org/library/papers/37804821PubMed
940384385Shen Shuai II Recipe alleviates renal fibrosis in chronic kidney disease by improving of hypoxia and inhibition of TLR4/MyD88/NF-κB/NLRP3 pathway.Ren Fail2025https://conductscience.org/library/papers/40384385PubMed
1034124032An Overview of the Posttranslational Modifications and Related Molecular Mechanisms in Diabetic Nephropathy.Front Cell Dev Biol2021https://conductscience.org/library/papers/34124032PubMed
1133280239Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.J Cell Mol Med2021https://conductscience.org/library/papers/33280239PubMed
1238625103Phlorizin Limits Bovine Viral Diarrhea Virus Infection in Mice via Regulating Gut Microbiota Composition.J Agric Food Chem2024https://conductscience.org/library/papers/38625103PubMed
1335490491
Protective mechanism of traditional Chinese medicine guizhi fuling pills against carbon tetrachloride-induced kidney damage is through inhibiting oxidative stress, inflammation and regulating the intestinal flora.
Phytomedicine2022https://conductscience.org/library/papers/35490491PubMed
1437364420FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis.Phytomedicine2023https://conductscience.org/library/papers/37364420PubMed
1536239349Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota.Acta Biochim Biophys Sin (Shanghai)2022https://conductscience.org/library/papers/36239349PubMed
1632758603Polysaccharides from Armillariella tabescens mycelia ameliorate renal damage in type 2 diabetic mice.Int J Biol Macromol2020https://conductscience.org/library/papers/32758603PubMed
1736787845Yi-Shen-Hua-Shi granule ameliorates diabetic kidney disease by the "gut-kidney axis".J Ethnopharmacol2023https://conductscience.org/library/papers/36787845PubMed
1836966849A proteoglycan isolated from Ganoderma lucidum attenuates diabetic kidney disease by inhibiting oxidative stress-induced renal fibrosis both in vitro and in vivo.J Ethnopharmacol2023https://conductscience.org/library/papers/36966849PubMed
1936863097Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.Biomed Pharmacother2023https://conductscience.org/library/papers/36863097PubMed
2036583468Abelmoschus Manihot ameliorates the levels of circulating metabolites in diabetic nephropathy by modulating gut microbiota in non-obese diabetes mice.Microb Biotechnol2023https://conductscience.org/library/papers/36583468PubMed

See all 37 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn PapersSource
42812582Global Research Trends in Traditional Chinese Medicine for Diabetic Kidney Disease: A 20-Year Bibliometric Analysis.J Inflamm Res2026https://conductscience.org/library/papers/42812582PubMed
42076830Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut-Kidney Axis Restoration and TLR4/NF-κB/NLRP3 Suppression.J Diabetes Res2026https://conductscience.org/library/papers/42076830PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42076830

GET https://conductscience.org/api/papers/v1/42076830/references?page=2